Ignite Creation Date:
2025-12-24 @ 9:48 PM
Ignite Modification Date:
2026-01-04 @ 2:52 AM
Study NCT ID:
NCT03816332
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-09
First Post:
2019-01-24
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-11-08
Start Date Type:
ACTUAL
Primary Completion Date:
2022-10-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-09-19
Completion Date Type:
ESTIMATED
First Submit Date:
2019-01-24
First Submit QC Date:
None
Study First Post Date:
2019-01-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-06-08
Results First Submit QC Date:
None
Results First Post Date:
2023-06-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-20
Last Update Post Date:
2025-10-09
Last Update Post Date Type:
ESTIMATED